Company: SXTPW
Filing Date: 2025-06-06
Form Type: DRS
Source: 0001213900-25-052232
Chunk: 64

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-06-06
Form: DRS
Chunk 64
---
 use reasonable best efforts
to arrange for the sale of the securities by us. Therefore, we may not sell all of the shares of common stock, Pre-Funded Warrants and
Warrants being offered. The terms of this offering are subject to market conditions and negotiations between us, the placement agent and
prospective investors. The placement agent does not guarantee that it will be able to raise new capital in any prospective offering. The
placement agent may engage sub-agents or selected dealers to assist with the offering.

Investors purchasing
securities offered hereby will have the option to execute a securities purchase agreement with us. In addition to rights and remedies
available to all purchasers in this offering under federal securities and state law, the purchasers which enter into a securities purchase
agreement will also be able to bring claims of breach of contract against us. The ability to pursue a claim for breach of contract is
material to larger purchasers in this offering as a means to enforce the following covenants uniquely available to them under the securities
purchase agreement: (i) a covenant to not enter into variable rate financings for a period of one year following the closing
of the offering, subject to an exception; and (ii) a covenant to not enter into any equity financings for days from
closing of the offering, subject to certain exceptions. The nature of the representations, warranties and covenants in the securities
purchase agreements include:

| ● | standard                                                                                                                                  
 issuer representations and warranties on matters such as organization, qualification, authorization, no conflict, no governmental filings 
 required, current in SEC filings, no litigation, labor or other compliance issues, environmental, intellectual property and title matters 
 and compliance with various laws such as the Foreign Corrupt Practices Act; and                                                           |

| ● | covenants                                                                                                                                   
 regarding matters such as registration of Warrant shares, no integration with other offerings, no stockholder rights plans, no material     
 nonpublic information, use of proceeds, indemnification of purchasers, reservation and listing of shares of common stock, and no subsequent 
 equity sales for 45 days, subject to certain exceptions.                                                                                    |

The securities will be offered at a fixed combined public offering
price and are expected to be issued in a single closing. We expect this offering to be completed on or about
, 2025.

We expect to deliver
the shares and securities to the purchasers in the offering on or about , 2025, subject to satisfaction
of certain conditions

Fees and Expenses

The following table